KLAS: Top interface engines have an interoperability edge

“Interface engine vendors are no longer being considered solely for their integration solution,” states a new report from market researcher KLAS.

“Spurred by meaningful use, health information exchange (HIE), accountable care organizations (ACOs) and other healthcare reform initiatives, healthcare providers are considering bigger interoperability goals that involve multiple technologies" to enable data flow within and between facilities, the Orem, Utah company continued.

The report, titled “Interface Engines: Beyond Interoperability,” scrutinizes vendor performance, interface engine market trends and the interoperability strategies vendors are pursuing to meet the industry's requirements.

Providers need a higher level of interoperability, and because cost is a major consideration, many are looking to interface engines to achieve it "with simple sophistication listed as the most sought-after functionality," the report noted. "Understanding how each tool performs, what hospital size they perform best with, and if their offerings match providers' needs is critical in choosing the best fit."

Corepoint Health is the top-rated vendor in the report, with 96.3 points out of 100, and is experiencing tremendous growth in its client base. It had the largest presence of any vendor in smaller healthcare facilities (fewer than 200 beds) but very few clients in facilities with more than 500 beds.

Running a very close second with 96.0 points was InterSystems, the report states. Almost all customers using InterSystems Ensemble were facilities with more than 500 beds. Ensemble achieved the highest increase in satisfaction score of any vendor product over the past year, the report found.

Looking forward, many vendors are shifting their focus to marketing capabilities beyond the interface engine, according to KLAS. “[As] a consequence, some vendors such as InterSystems, Lawson and Orion Helath have had success leveraging their interface engine technology to meet providers’ other needs for sharing data.”

HIE tools and strategy are where the majority of vendors are focusing their attention, KLAS reported.

"After functionality, technology, development and advancement rank as [the] most desirable selection factors," concluded the report. "So far, many of these interface engine vendors are meeting provider expectations, but only because they have mastered the management of the interface engine and progressed beyond their single solution. Many of the top vendors in this report have successfully married a user-friendly system, aggressive product development and additional technology offerings such as HIE into a package underscored by excellent service and support.”

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.